🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Management of Abdominal Post-surgical Scar With Ozoaqua Versus Standard Care

RecruitingNAAges 18 Years - anyFemaleLaboratorios Ozoaqua
NCT07678372 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A prospective, randomized clinical study with a blinded evaluator to compare a post-surgical abdominal scar care protocol using Ozoaqua products versus standard care in patients undergoing open abdominal surgery. The primary objective is to assess whether the use of Ozoaqua, initiated in the immediate postoperative period according to wound evolution, improves abdominal scar quality at 3 months compared with usual care. The proposed design is an initial single-center study at the Clínica Universidad de Navarra, with 1:1 random allocation to two parallel arms: an intervention group receiving standard care plus Ozoaqua ozonated soap and oil, and a control group receiving standard care only. The primary scar assessment will be performed by a blinded evaluator, while treatment will be open-label due to the nature of the topical intervention. The target population consists of adult patients

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18 years * Scheduled open abdominal surgery * Primary wound closure * Assessable linear abdominal scar * Signed informed consent * Ability to complete 3-month follow-up Exclusion Criteria: * Known allergy to treatment components * Active infection or significant dehiscence in the immediate postoperative period * Planned use of specific scar treatments -silicone products, laser therapy, local corticosteroids- except as clinical rescue treatment * Inability to complete follow-up * Participation in another study that may interfere with wound healing
💊

What it tests

  • Ozonated product-based protocol for scar hygiene and care
📍

Where

1 site
Clínica Universidad de Navarra
Pamplona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy